These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6352634

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas.
    Blumer JL, Stern RC, Klinger JD, Yamashita TS, Meyers CM, Blum A, Reed MD.
    Am J Med; 1985 Aug 09; 79(2A):37-46. PubMed ID: 3895917
    [Abstract] [Full Text] [Related]

  • 23. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
    Zobell JT, Waters CD, Young DC, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG.
    Pediatr Pulmonol; 2013 Feb 09; 48(2):107-22. PubMed ID: 22949297
    [Abstract] [Full Text] [Related]

  • 24. Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis with high or conventional doses of ceftazidime.
    De Boeck K, Breysem L.
    J Antimicrob Chemother; 1998 Mar 09; 41(3):407-9. PubMed ID: 9578170
    [Abstract] [Full Text] [Related]

  • 25. Photosensitivity due to ambulatory intravenous ceftazidime in cystic fibrosis patient.
    Vinks SA, Heijerman HG, de Jonge P, Bakker W.
    Lancet; 1993 May 08; 341(8854):1221-2. PubMed ID: 8098116
    [No Abstract] [Full Text] [Related]

  • 26. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
    Michalsen H, Bergan T.
    Chemotherapy; 1980 May 08; 26(2):135-40. PubMed ID: 7363708
    [Abstract] [Full Text] [Related]

  • 27. Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.
    Clumeck N, Gordts B, Dab I, Jaspar N, Van Laethem Y, Butzler JP.
    J Antimicrob Chemother; 1983 Jul 08; 12 Suppl A():207-11. PubMed ID: 6352620
    [Abstract] [Full Text] [Related]

  • 28. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
    Goldfarb J, Stern RC, Reed MD, Yamashita TS, Myers CM, Blumer JL.
    Am J Med; 1987 Apr 27; 82(4A):174-9. PubMed ID: 3555032
    [Abstract] [Full Text] [Related]

  • 29. Ceftazidime: a new approach in the treatment of moderate and severe infections.
    Abbas AM, Taylor MC, Newby D, Jones RB, Rigby CC, Haste AR, Cantor AM.
    J Antimicrob Chemother; 1983 Jul 27; 12 Suppl A():147-52. PubMed ID: 6352615
    [Abstract] [Full Text] [Related]

  • 30. Adverse reactions to piperacillin in adults with cystic fibrosis.
    Stead RJ, Kennedy HG, Hodson ME, Batten JC.
    Thorax; 1985 Mar 27; 40(3):184-6. PubMed ID: 3983886
    [Abstract] [Full Text] [Related]

  • 31. [Ceftazidime absorption into bronchial secretions in mucoviscidosis patients].
    Berthelot G, Lenoir G, Grenier B, Tournier G, Sardet A, Steru D, Bergogne-Berezin E.
    Pathol Biol (Paris); 1985 May 27; 33(5):430-4. PubMed ID: 3897974
    [Abstract] [Full Text] [Related]

  • 32. Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
    Fitzpatrick SB, Rosenstein BJ.
    Clin Pediatr (Phila); 1983 Sep 27; 22(9):628-30. PubMed ID: 6224623
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. British Thoracic Society Research Committee.
    Thorax; 1985 May 27; 40(5):358-63. PubMed ID: 2862713
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.
    Høiby N, Koch C.
    Thorax; 1990 Nov 27; 45(11):881-4. PubMed ID: 2256020
    [No Abstract] [Full Text] [Related]

  • 37. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G, Jahnke N, Remmington T.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD008319. PubMed ID: 23235659
    [Abstract] [Full Text] [Related]

  • 38. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D, Stableforth D.
    Drugs; 2000 Nov 12; 60(5):1053-64. PubMed ID: 11129122
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serum and sputum concentrations of ceftazidime in patients with cystic fibrosis.
    Turner A, Pedler SJ, Carswell F, Spencer GR, Speller DC.
    J Antimicrob Chemother; 1984 Nov 12; 14(5):521-7. PubMed ID: 6392281
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.